Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Filings indexed 267 across all filing types
Latest filing 2018-11-22 Regulatory Filings
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is an official announcement regarding an upcoming Investor Relations (IR) event (a Non-Deal Roadshow). It provides details such as the date, location, purpose, and method of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the regulatory filing format for corporate events in Korea (KIND system), it is classified as a Regulatory Filing (RNS).
2018-11-22 Korean
증권발행결과(자율공시)(제3자배정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Antrogen regarding the 'Results of Securities Issuance' (증권 발행결과) following a third-party capital increase (유상증자). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2018-11-20 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Anterogen' (안트로젠) covering the period from 2018.01.01 to 2018.09.30. It contains detailed financial information, business descriptions, management discussions, and capital structure data. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (quarterly) is classified as an Interim / Quarterly Report (IR). 9M 2018
2018-11-14 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정), which involves the issuance of new shares (third-party allocation). This falls under the category of capital structure changes and financing activities. According to the provided definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2018-11-08 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) titled '증권 발행결과' (Securities Issuance Result) regarding a third-party capital increase (유상증자). It details the issuance of convertible preferred shares and explicitly states that the issuance did not occur due to non-payment by the designated parties. This falls under the category of share issuance or capital change announcements.
2018-10-31 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that materials will be posted on the company website or KIND. Since it is an announcement of an event rather than the presentation itself, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2018-10-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.